GlobeNewswire
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
📈
AI Sentiment
Highly Positive
8/10
ProMIS Neurosciences Inc. (ON) News
Latest updates and market news for PMN
1 news
Dec 7 - Dec 13, 2025
Page 1
Share this news page